Vioxx Lawsuit

Merck & Co.‘s Vioxx, a non-steroidal anti-inflammatory drug (NSAID), won approval from the Food and Drug Administration (FDA) in May 1999 for use as a pain reliever and anti-inflammatory drug related to osteoarthritis.

Vioxx was withdrawn in 2004 due to safety concerns linking Vioxx to a higher risk of heart attacks and strokes.

Doctors have prescribed Vioxx to treat acute pain in adults and menstrual pain, as well as signs and symptoms of rheumatoid arthritis in adults and children.

About 105 million people have taken Vioxx worldwide since it was introduced.